Safety of the second dose of the ChAdOx1 nCoV-19 vaccine in people with persistent anti-platelet factor 4 antibodies.
Noppacharn UaprasertSasinipa TrithiphenAutcharaporn SukpermBenjaporn AkkawatPhandee WatanaboonyongcharoenRattaporn VichitratchaneekornThanisa TongbaiWatsamon JantarabenjakulLeilani PaitoonpongPonlapat RojnuckarinPublished in: Research and practice in thrombosis and haemostasis (2021)
Keyphrases